The omicron-fighting COVID-19 vaccine is now approved for children ages 6 months and older, the U.S. Food and Drug Administration said Thursday.
Children under age 5 previously weren’t permitted to receive the bivalent booster.
“We encourage parents and caregivers of those eligible to consider doing so — especially as we head into the holidays and winter months where more time will be spent indoors,” FDA Commissioner Robert M. Califf said Thursday.
